Amy Schumer and Connie Britton Participate in Midi Health’s $63M Series B Funding Round
**Amy Schumer and Connie Britton Participate in Midi Health’s $63M Series B Funding Round: A Major Step Forward for Women’s Healthcare**
In a significant move that underscores the growing importance of women’s health in the tech and healthcare sectors, comedian and actress Amy Schumer and actress Connie Britton have joined forces with other investors to support Midi Health, a digital health platform focused on menopause care. The company recently announced the successful completion of a $63 million Series B funding round, signaling a major step forward in addressing the often-overlooked healthcare needs of women in midlife.
### **Midi Health: A New Era in Menopause Care**
Midi Health is a digital health startup that aims to revolutionize the way women experience and manage menopause. Founded by a team of healthcare professionals and technologists, the company offers personalized, evidence-based care for women going through perimenopause and menopause. Through a combination of telemedicine, data-driven insights, and expert consultations, Midi Health provides a comprehensive approach to managing the physical, emotional, and psychological challenges that come with this stage of life.
Menopause, a natural biological process that marks the end of a woman’s reproductive years, affects millions of women globally. Yet, it remains an under-discussed and under-researched area in healthcare. Symptoms such as hot flashes, mood swings, sleep disturbances, and cognitive changes can significantly impact a woman’s quality of life, but many women struggle to find adequate care and support. Midi Health aims to fill this gap by offering accessible, high-quality care tailored to individual needs.
### **Amy Schumer and Connie Britton: Advocates for Women’s Health**
Amy Schumer and Connie Britton are no strangers to advocating for women’s issues. Schumer, known for her candid humor and outspoken advocacy on topics like body image, reproductive rights, and mental health, has increasingly used her platform to raise awareness about women’s healthcare challenges. In 2022, Schumer publicly discussed her own struggles with endometriosis, a painful condition affecting the uterus, which led her to undergo surgery. Her involvement in Midi Health aligns with her broader mission to break taboos around women’s health and ensure that women receive the care they deserve.
Connie Britton, an Emmy-nominated actress best known for her roles in *Friday Night Lights* and *Nashville*, has long been an advocate for gender equality and women’s empowerment. She has worked with organizations like the United Nations Development Programme (UNDP) to promote women’s rights globally. By investing in Midi Health, Britton is furthering her commitment to improving the lives of women, particularly in areas where healthcare has historically fallen short.
Both Schumer and Britton’s participation in the funding round not only brings financial support to Midi Health but also shines a spotlight on the critical need for better healthcare solutions for women in midlife. Their involvement is likely to raise awareness about menopause and encourage more women to seek the care they need.
### **The $63 Million Series B Funding Round: What It Means for Midi Health**
The $63 million Series B funding round, led by top-tier investors, will enable Midi Health to expand its services and reach more women across the United States. The company plans to use the funds to enhance its digital platform, increase its clinical offerings, and grow its team of healthcare professionals specializing in menopause care. Additionally, the funding will support research and development efforts aimed at improving the understanding of menopause and developing new treatment options.
Midi Health’s CEO, Joanna Strober, expressed her excitement about the funding round and the involvement of high-profile investors like Schumer and Britton. “We are thrilled to have Amy and Connie on board as we work to transform menopause care for women everywhere,” Strober said in a statement. “Their passion for women’s health and their commitment to breaking down barriers make them ideal partners in our mission.”
### **A Growing Market for Women’s Health Tech**
The success of Midi Health’s Series B funding round is part of a broader trend in the healthcare industry, where women’s health tech—often referred to as “femtech”—is gaining traction. According to Frost & Sullivan, the global femtech market is expected to reach $50 billion by 2025, driven by increasing awareness of women’s health issues and the growing demand for personalized healthcare solutions.
Historically, women’s health has been underfunded and under-researched, but companies like Midi Health are changing that narrative. By focusing on menopause, a stage of life that affects nearly half of the population but has received little attention from the medical community, Midi Health is addressing a critical gap in healthcare.
### **The Future of Menopause Care**
As Midi Health continues to grow, it has the potential to set a new standard for menopause care. The company’s digital-first approach allows women to access care from the comfort of their homes, making it easier for those who may not have access to specialized healthcare providers in their local area. By leveraging technology, Midi Health can offer personalized treatment plans based on each